Cerebral germinoma is rare. Although the imaging of the germinoma is very evocative, it's very polymorphic clinical expression is at the origin of misguided diagnosis, as illustrated in our case. We report the case of a 10-year-old girl with diabetes insipidus evolving for 12 months associated with a decrease in visual acuity. Brain MRI (Magnetic Resonance Imaging) revealed a tumor process in the suprasellar region. Th e stereotaxic biopsy of the tumor confi rmed the diagnosis of the hypothalamic germinoma, which allowed the patient to be treated by radiotherapy and chemotherapy. Th e incidence of cerebral germinoma, its clinical (principally diabetes insipidus) and radiological features as well as therapeutic strategies are discussed hereby. Th e cerebral germinomas are germ-line tumors representing 4% of childhood brain tumors (Resetkova et al. 2013 ). We report a new observation of cerebral germinoma discovered through a polyuric polydipsic syndrome. Th e literature has been reviewed with discussion of the diagnosis, the radiological criteria, and the treatment of these tumors.
Th e cerebral germinomas are germ-line tumors representing 4% of childhood brain tumors (Resetkova et al. 2013 ). We report a new observation of cerebral germinoma discovered through a polyuric polydipsic syndrome. Th e literature has been reviewed with discussion of the diagnosis, the radiological criteria, and the treatment of these tumors.
Subject and Results
A 10-year-old girl was hospitalized in the pediatric neurology unit for drowsiness and cognitive disorders. She also complained of frontal headaches and progressive polyuric polydipsic syndrome (drinking between 3 and 7 liters per day), associated with growth failure. Medical history was unremarkable, except for a defi cit in Von Willebrandt factor detected during the pre-operative exams for adenoids. Th e clinical examination was normal; no sign of puberty was observed. A blood sample analysis showed a low free T4 (fT4) level at 7.4 pmol/l (reference 10.4-24.0 pmol/l) with normal t hyroid stimulating hormone (TSH) at 3.7 mU/l (reference 0.70-5.3 mU/l), increased level of prolactin at 63.3 μg/l (reference 5.0-23.0 μg/l), and low levels of gonadotropins. Plasma sodium and glucose were within the normal range. Th erefore, central hypothyroidism and diabetes insipidus (DI) were suspected. Urine osmolality was low at 88 mOsm/kg (reference 300-900 mOsm/kg), while plasma osmolality was normal at 281 mOsm/kg. A hydric deprivation test was not performed because the polyuric polydypsic syndrome was severe (3 to 7 liters per day). Th e concentration of anti-diuretic hormone (ADH) was low <0.5 pg/ml (reference 0.5-14 pg/ml) confi rming the DI. A glucagon test was performed (Table 1) to explore the anterior pituitary, there was no signifi cant increase of plasma cortisol and growth hormone (GH) levels aft er stimulation. Th e defi cit in fT4 and cortisol were treated by L-Th yroxine® 50 μg/day and hydrocortisone, while DI was successfully treated by Minirin®.
To confi rm the central origin of the hormonal defi cit, brain MRI was performed and showed a major hypothalamic mass developed above the hypothalamus, enhancing intensely aft er contrast and compressing the optic chiasm. Th ere was no associated hydrocephalus. Th e medullary MRI was normal, without evidence of other tumor localizations. Th e ophthalmologic exam showed low visual acuity due to the optic nerves compression. Th e visual fi eld test was disrupted to the right eye and showed a left lateral hemianopia to the left eye.
Plasma levels of the alpha1-foetoprotein were measured at 8.3 μg/l (reference <9.0 μg/l) and of β-human chorionic gonadotropin (β-HCG) at <0.16 mUI/ml (reference <0.16 mUI/ml). Th e lumbar puncture showed similar low marker concentrations and no malignant cells. Positron emission tomography-methionine computed tomography (PET-methionine CT) revealed a hypermetabolic core inside the tumor. A biopsy was fi nally performed through neuronavigation ( Figure 1) . Th e cytological analysis showed increased nuclei size, irregular contour, and hyperchromatic. Th ese cells were dissociated by relatively large vascular structures with a focal pseudoepithelial palissadic disposition. Focal glandular epithelial diff erentiation was also focalized. No necrosis range was formally objectifi ed. Immunologically, the tumor cells express antigen CD117, weakly alpha1-foetoprotein, and none β-HCG. On the other hand, there was a persistence of the nuclear immunostaining of neoplastic cells by BAF47/INI1. Th e MRI, histological, and immunohistochemical examinations confi rmed a germ cell tumor, rather type germinoma with focal epithelial diff erentiation even beginner embryonal carcinoma. In order to preserve the patient's fertility, ovarian tissue cryopreservation was performed, the patient was consequently treated by chemotherapy and radiotherapy (Resetkova et al. 2013 ).
Discussion and conclusion
Germ cell tumors contribute to 4% of childhood brain tumors, with an incidence peaking around puberty. Th ey occur mostly in the testes (25%), ovaries (25%), sacrococcygeal region (20%), and the central nervous system (20%) (Calaminus et al. 2013) . Th e germ cell tumors of the central nervous system are rare and usually arise from the midline structures (Hayashi et al. 2009 ). It has been hypothesized that the pathogenesis is a result of the aberrant migration of the primordial germ cells from the midline embryonic disk. Th eir most common sites of occurrence include the pineal gland and the supra or neurohypophyseal regions, some tumors being bifocal (Kishore et al. 2014) . the intracranial germ cell tumors are further divided into 6 histologic subtypes: germinoma, teratoma, embryonal carcinoma, choriocarcinoma, yolk sac tumor, and mixed tumor (Louis et al. 2007) . Th e germinomas account for 50 to 66% of all the intracranial germ cell tumors.
Th e clinical expression of the germinomas is polymorphic. Th ey are most oft en revealed by DI, as shown in our observation. Th e young patient presented with an ongoing polyuric polydipsic syndrome at fi rst (since several months) and in the absence of other symptoms, the behavior was regarded as a probable mental disorder, like potamania, especially since her parents were divorcing. Although the etiologic diagnosis of polyuric polydipsic syndrome can be misleading, there are some diff erences between symptoms of DI and potomania. DI appears suddenly, even overnight, and is principally accompanied by loss of considerable volumes of urine, as opposed to potomania, which does not occur suddenly and does not present with nycturia. However, the water de privation test can be very helpful to differentiate between potomania and DI (Metropulos and Antoon 2015) . In our case, the water deprivation test was not available, as the patient's drinking needs were too important to perform it. Another method to replace this test is the ADH-MRI-method (Robertson 2016). It is based on two observations. Th e fi rst one implies that basal plasma ADH levels are always low or undetectable in potomania and pituitary diabetes insipidus, though they are normal or elevated in nephrogenic DI. Th e second observation involves an MRI. Th e neurohypophysis appears with a high signal in T1. Th is signal is present or enlarged in potomania, but absent or abnormally small in the pituitary DI. Th erefore, these three types of polydipsia can be diff erentiated following two steps, like described by Robertson (2016) (Figure 2 ). First, a measure of basal plasma ADH and urine osmolarity (in unrestricted fl uid intake conditions). If plasma ADH is normal or elevated >2.0 pg/ml, while urine osmolarity is low (<300 mosm/l), the patient suff ers from nephrogenic DI. If plasma ADH is low or undetectable <1 pg/ml when urine osmolarity is also low, the brain MRI is needed. It can determine whether the neurohypophyseal hypersignal is absent, indicating pituitary DI, or normal or abnormally large, indicating potomania. MRI can help to identify signs of the pathology causing the disorder. In this clinical presentation, the germinoma appear as an isointense T1, hyperintense T2 mass with marked gadolinium enhancement (Robertson 2016) .
Supracellar germinoma can also be manifested by lead to anterior pituitary defi ciencies in more than 50% of patients. Moderate hyperprolactinemia is present in most cases (30 to 60 ng/ml), which suggest hypothalamic lesions caused by brain tumors (e.g. craniopharyngiomas) or hypothalamic-pituitary infi ltrations (such as sarcoidosis or histiocytosis X) are responsible for hyperprolactinemia due to loss of dopamine inhibition on secretion of pituitary prolactin (Teinturier and Bougneres 2002) . As illustrated by our observation, the young girl presented low levels of TSH, GH, cortisol, and ADH, which can be explained by a compression of the infundibulum, stalk and/or pituitary gland by the tumor. Regarding the diff erential diagnosis, some authors have described pubertal delay due to the hypogonadism and hyperprolactinemia (Echevarria et al. 2008 ). However, the tumor can also lead to an early onset of puberty (before 8 years for girls). Th e precocious puberty can arise in 5% of patients in pineal and/or hypothalamic tumors. β-HCG and luteinizing hormone (LH) levels may be elevated in some patients with precocious puberty, and choriocarcinomas are more likely to be present with precocious puberty than any other type of germ cell tumors. Finally, visual disturbances linked intracranial hypertension are oft en described (Hoff man et al. 1991) . Th e presence of specifi c protein markers (β-HCG and alfa-fetoprotein) that can be secreted by some tumors may be an important tool in the diagnosis of the germ cell tumors. At high levels, these protein markers can be measured in the serum, although cerebrospinal fl uid levels are more sensitive and reliable parameters. Low levels of β-HCG have been detected in a variety of tumors. It may be a non-specifi c marker of malignancy. A mild elevation of β-HCG has been noted in the syncytiotrophoblastic form of the germinoma (Echevarria et al. 2008) . Increased alfafetoprotein levels may indicate the presence of cancer, most commonly liver cancer, cancer of the ovary, or the germ cell tumor. However, not every cancer will produce signifi cant quantities of alfa-fetoprotein. Th e defi nitive diagnosis of an intracranial germ cell tumor usually requires histological confi rmation. In our case, a biopsy of the mass was required to confi rm the diagnostic because the tumor markers were not elevated (National Cancer Institute 2015) .
Th e treatment of this tumor is based on the International Society of Peadiatric Oncologic (SIOP) CNS GCT II-non-metastatic protocol. Th is protocol includes primary chemotherapy consisting of Carboplatin and Etoposide, alternated with Ifosfamide and Etoposide. Radiotherapy should follow chemotherapy, or surgical resection of a residual mass has to be performed as soon as possible, if it is necessary. Th e radiotherapy will consist of entire ventricular irradiation, ensuring that the original area of the tumor is included (Kim and Park 2015) . Th e treatment success rate for germinomas depends more on the radiation volume, which should cover the entire ventricular space than the radiation dose itself. Neoadjuvant chemotherapy is given to reduce the size of the tumor in order to lower the radiation dose. Th ese therapies have the merit of the decreasing long term neurological consequences of radiotherapy. Th e prognosis for patients with germinomas is quite good, with many reports indicating the survival rate being greater than 90% fi ve years following the diagnosis and treatment. Th e young girl patient had her third course of chemotherapy following the SIOP CNS GCT II-protocol in the context of a nonsecreting cerebral germinoma. Chemotherapy was very well tolerated.
